During the past decade, 529-Hospital Provincial de Zamora conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "529-Hospital Provincial de Zamora" are "Schizophrenia" (3 trials) and "Depressive Disorder, Major" (1 trials). Many other conditions were trialed in "529-Hospital Provincial de Zamora" in a lesser frequency.

Most popular intervention types in "529-Hospital Provincial de Zamora" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Pimavanserin" (2 trials), "PP1M" (1 trials), "PP3M 350 mg eq." (1 trials) and "PP3M 525 mg eq." (1 trials). Other intervention names were less common.

The vast majority of trials in "529-Hospital Provincial de Zamora" are 4 trials for "All" genders.

Currently, there are NaN active trials in "529-Hospital Provincial de Zamora". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in 529-Hospital Provincial de Zamora, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in 529-Hospital Provincial de Zamora, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".